Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership $14.67 -0.81 (-5.23%) Closing price 04:00 PM EasternExtended Trading$14.78 +0.11 (+0.75%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$107.05KNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$2.89M Get ARQT Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARQT Insider Buying and Selling by Quarter Arcutis Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/14/2025Patrick BurnettInsiderSell5,750$15.07$86,652.50 7/10/2025Patrick BurnettInsiderSell23,000$15.05$346,150.00 6/18/2025Howard G WelgusDirectorSell10,139$13.37$135,558.43 6/13/2025Patrick J HeronDirectorBuy2,646$13.08$34,609.68 6/5/2025Patrick J HeronDirectorBuy378$13.41$5,068.98 6/4/2025Patrick J HeronDirectorBuy1,890$13.32$25,174.80 5/28/2025Masaru MatsudaInsiderSell1,800$13.78$24,804.00 5/21/2025Patrick J HeronDirectorBuy2,520$13.66$34,423.20 5/19/2025Larry Todd EdwardsInsiderSell7,451$14.07$104,835.57 5/8/2025Patrick BurnettInsiderSell3,871$13.59$52,606.89 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/2/2025Masaru MatsudaInsiderSell5,030$15.20$76,456.00 3/24/2025Todd Franklin WatanabeInsiderSell1,500$17.52$26,280.00 3/17/2025Todd Franklin WatanabeInsiderSell1,200$17.61$21,132.00 3/14/2025Patrick BurnettInsiderSell12,242$15.04$184,119.68 3/3/2025Howard G WelgusDirectorSell10,000$13.00$130,000.00 3/3/2025Patrick BurnettInsiderSell2,819$13.03$36,731.57 2/3/2025Howard G WelgusDirectorSell10,000$12.71$127,100.00 2/3/2025Masaru MatsudaInsiderSell8,338$12.70$105,892.60 1/2/2025Howard G WelgusDirectorSell10,000$14.67$146,700.00 12/31/2024Patrick BurnettInsiderSell1,691$14.00$23,674.00 12/20/2024Todd Franklin WatanabeInsiderSell15,000$15.17$227,550.00 12/2/2024Howard G WelgusDirectorSell10,000$12.51$125,100.00 11/30/2024Larry Todd EdwardsInsiderBuy1,093$7.11$7,771.23 11/22/2024Patrick BurnettInsiderSell16,023$10.14$162,473.22 11/19/2024Masaru MatsudaInsiderSell1,775$9.68$17,182.00 11/15/2024Patrick BurnettInsiderSell100$10.03$1,003.00 11/11/2024Terrie CurranDirectorSell8,687$10.85$94,253.95 11/4/2024Masaru MatsudaInsiderSell5,015$8.68$43,530.20 11/1/2024Howard G WelgusDirectorSell10,000$8.65$86,500.00 10/2/2024Larry Todd EdwardsSVPSell3,725$10.01$37,287.25 10/1/2024Howard G WelgusDirectorSell10,000$9.26$92,600.00 9/24/2024David Joseph TopperCFOSell11,626$9.48$110,214.48 9/3/2024Howard G WelgusDirectorSell10,000$10.77$107,700.00 8/19/2024Patrick BurnettInsiderSell1,728$8.29$14,325.12 8/2/2024Masaru MatsudaInsiderSell5,220$9.02$47,084.40 8/1/2024Howard G WelgusDirectorSell10,000$9.87$98,700.00 (Data available from 1/1/2013 forward) ARQT Insider Trading Activity - Frequently Asked Questions Who is on Arcutis Biotherapeutics' Insider Roster? The list of insiders at Arcutis Biotherapeutics includes David Joseph Topper, Howard G Welgus, Larry Todd Edwards, Life Sciences Viii L Frazier, Masaru Matsuda, Patricia A Turney, Patrick Burnett, Patrick J Heron, Scott L Burrows, Terrie Curran, and Todd Franklin Watanabe. Learn more on insiders at ARQT. What percentage of Arcutis Biotherapeutics stock is owned by insiders? 9.40% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings. Which Arcutis Biotherapeutics insiders have been buying company stock? The following insiders have purchased ARQT shares in the last 24 months: Larry Todd Edwards ($7,771.23), Life Sciences Viii L Frazier ($200,000.00), and Patrick J Heron ($99,276.66). How much insider buying is happening at Arcutis Biotherapeutics? Insiders have purchased a total of 88,527 ARQT shares in the last 24 months for a total of $307,047.89 bought. Which Arcutis Biotherapeutics insiders have been selling company stock? The following insiders have sold ARQT shares in the last 24 months: David Joseph Topper ($110,214.48), Howard G Welgus ($1,143,058.43), Larry Todd Edwards ($210,730.02), Masaru Matsuda ($376,416.15), Patrick Burnett ($1,124,975.68), Terrie Curran ($94,253.95), and Todd Franklin Watanabe ($274,962.00). How much insider selling is happening at Arcutis Biotherapeutics? Insiders have sold a total of 284,685 Arcutis Biotherapeutics shares in the last 24 months for a total of $3,334,610.71 sold. Arcutis Biotherapeutics Key ExecutivesMr. Todd Franklin Watanabe M.A. (Age 56)President, CEO & Director Compensation: $1.01M2 recent tradesDr. Bhaskar Chaudhuri Ph.D. (Age 69)Co-Founder & Independent Director Compensation: $60.83kDr. Patrick E. Burnett M.D. (Age 52)Ph.D., Senior VP & Chief Medical Officer Compensation: $722.94kMr. L. Todd Edwards (Age 60)Senior VP & Chief Commercial Officer Compensation: $755.64k1 recent tradesMr. David J. Topper (Age 66)Senior VP & Chief Financial Officer Mr. Rajvir MadanChief Digital & Technology OfficerMs. Latha VairavanVice President of Finance & Investor RelationsMs. Courtney Barton (Age 41)VP and Chief Compliance Officer & Privacy Officer Mr. Masaru Matsuda Esq. (Age 53)J.D., Senior VP, General Counsel & Corporate Secretary Compensation: $626.22k3 recent tradesMs. Amanda SheldonHead of Corporate Communications More Insider Trading Tools from MarketBeat Related Companies Grifols Insider Ownership TG Therapeutics Insider Ownership Nuvalent Insider Ownership Lantheus Insider Ownership Axsome Therapeutics Insider Ownership CRISPR Therapeutics Insider Ownership ADMA Biologics Insider Ownership Vaxcyte Insider Ownership Rhythm Pharmaceuticals Insider Ownership Cytokinetics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:ARQT) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcutis Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
